Back to search

Reishi, Lingzhi · 2025 · Journal Article

Medium relevance

Bioactive secondary metabolites from an endophytic fungus Chloridium virescens GLQ05 and structural revision of alteamide.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support
SpeciesReishi, Lingzhi
JournalNatural product research
Year2025

Key points

  • Two previously undescribed metabolites, chlovirescenols A ( 1 ) and B ( 5 ), along with six known compounds including amides ( 2 - 4 ), macrolides ( 6 and 8 ), meroterpenoid ( 7 ), were obtained from the Ganoderma lucidum -derived endophyte Chloridium virescens GLQ05
  • Their structural elucidation was achieved through comprehensive spectroscopic analysis
  • Besides, the originally proposed structure of alteamide has been revised
  • In the LPS-stimulated RAW264.7 macrophage model, chlovirescenols A ( 1 ) and B ( 5 ) significantly suppressed the expression of the TNF-α as quantified with RT-qPCR analysis

Metadata-grounded summary

Citation abstract

Two previously undescribed metabolites, chlovirescenols A ( 1 ) and B ( 5 ), along with six known compounds including amides ( 2 - 4 ), macrolides ( 6 and 8 ), meroterpenoid ( 7 ), were obtained from the Ganoderma lucidum -derived endophyte Chloridium virescens GLQ05. Their structural elucidation was achieved through comprehensive spectroscopic analysis. Besides, the originally proposed structure of alteamide has been revised. In the LPS-stimulated RAW264.7 macrophage model, chlovirescenols A ( 1 ) and B ( 5 ) significantly suppressed the expression of the TNF-α as quantified with RT-qPCR analysis.

Citation

Liu S, Li PT, Li P, Qiu X, Cheng X, Luo Q, et al. (2025). Bioactive secondary metabolites from an endophytic fungus Chloridium virescens GLQ05 and structural revision of alteamide. Natural product research https://doi.org/10.1080/14786419.2025.2580440 PMID: 41186917

Open citation